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Iodine Status of Pregnant Women and Their Progeny
in the Minho Region of Portugal
Maria J. Costeira,1,2 Pedro Oliveira,1,3 Susana Ares,4 Gabriella Morreale de Escobar,4 and Joana A. Palha1
Background: Iodine sufficiency is particularly necessary throughout pregnancy, given its recognized impact on
psychomotor performance of the offspring. There are no recent reports about iodine status or supplementation in
Portugal, a country that the International Council for Control of Iodine Deficiency Disorders considered, in 2004,
to have probably reached iodine sufficiency. The objective of this study was to evaluate in the Minho region of
Portugal the iodine status of women throughout pregnancy and after delivery, and of their offspring.
Methods: Urinary iodine concentration (UI) was determined in 78 nonpregnant premenopausal women, in 140
pregnant women in the three trimesters of pregnancy and after delivery, and in their 142 offspring. Milk iodine
concentration was determined at day 3 and 3 months after delivery. The thyroid volume was determined in
women in the third trimester of pregnancy and 3 months after delivery and in infants at 3 months of age.
Results: Based on the World Health Organization criteria, both nonpregnant and pregnant women had iodine
deficiency (ID), as documented by median UI of <75 mg=L and milk iodine concentration of <100 mg=L. Goiter
was observed in 14% of the pregnant women. Concordant with the mother’s ID, median neonatal UI was low
(71 and 97 mg=L at 3 days and 3 months of age).
Conclusion: Portuguese women of the Minho region have an inadequate iodine intake, which may compromise
the potential for full psychomotor development of their progeny. These observations suggest that iodine sup-
plementation should be implemented throughout pregnancy and lactation in Portugal.
Introduction
Iodine is a trace element required for the biosynthesisof thyroid hormones and is obtained solely from external
sources. Thyroid hormones regulate various processes of
cellular metabolism, influencing all cells throughout life.
Particularly important is the role of thyroid hormones in
normal brain development and cognition. It has been shown
that insufficient iodine intake during pregnancy and lacta-
tion and in newborns may lead to irreversible brain damage
(1–9). The severity of this impairment varies from cretinism,
in regions of severe iodine deficiency (ID), to the inability
of children to achieve their potential intelligence quotient,
when iodine intake is mildly to moderately insufficient.
ID is, worldwide and after starvation, the most important
preventable cause of mental retardation. Since 1990 it has
been accepted as a basic human right that every child has
the right to an adequate supply of iodine to ensure its nor-
mal development and that every mother has the right to an
adequate iodine nutrition to ensure that her unborn child
reaches its potential mental development (4). Further, it
is believed that iodine-related neurodevelopmental deficits
of future generations can be prevented by promoting uni-
versal salt iodination and the use of iodine supplements
from the onset of pregnancy or when pregnancy is planned
(1–9).
The World Health Organization (WHO) urges its member
states to assess the extent and severity of ID disorders (IDD),
to promote universal salt iodination and to monitor the iodine
status of their populations (1–3). In Portugal, there are no
recent reports about iodine nutrition, percentage of house-
holds with access to iodized salt, or thyroid hormone con-
centrations and iodine intake in pregnant women (3). In this
study, therefore, we aimed to evaluate the iodine nutrition
of Portuguese women of fertile age, throughout pregnancy
and after delivery. This was done by nutritional question-
naires and measuring iodine concentrations in urine and
breast milk, and by determining their thyroid volume, as well
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as their offspring’s urinary iodine concentration (UI), thyroid
volume, and neonatal thyroid-stimulating hormone (TSH).
Subjects and Methods
Subjects
The study was carried out at the Centro Hospitalar do Alto
Ave, EPE (Hospital Sra da Oliveira, Guimara˜es) and at the
School of Health Sciences, University of Minho, Braga. Gui-
mara˜es and Braga are two cities located 50 km away from the
sea, with both urban and rural populations, in a total of about
0.7 million inhabitants. Between January 2003 and December
2005 we invited 140 pregnant women who were attending
the antenatal clinic in Centro Hospitalar do Alto Ave, EPE, to
have UI measured during and after pregnancy, as well as
thyroid ultrasound scans for thyroid volume. Demographic
information and clinical information were collected: age,
number of previous pregnancies, use of iodine supplements,
current and previous pathologies, and Graffar socioeconomic
and cultural status (10). The Graffar scale includes informa-
tion on the type of work and education of the women and
their partners, family income, characteristics of the house,
and the type of neighborhood. It provides a scale from I to V:
class I corresponds to families with higher education, better
jobs, and nicer houses and neighborhood; class V corresponds
to those with lower educational status andworst jobs, houses,
and neighborhood. A food-frequency questionnaire was used
to inquire about the number of fish meals per week, the use of
iodized salt and of iodine-containing multivitamin pills, and
whether the eating regimen was vegetarian. Exclusion criteria
were the use of drugs or of iodinated antiseptics, previous
diabetes, assisted medical reproduction, malformations of the
fetus, thyroidal and other endocrine dysfunctions, and heavy
smoking of more than 10 cigarettes daily.
Permission was given by 140 mothers to enroll their babies
in the study. Clinical information was recorded about deliv-
ery (gestational age and type of delivery), Apgar score, birth
weight, length, and head circumference. A total of 78 non-
pregnant healthy women of fertile age, with no pregnancies
reported for the previous year, were recruited from the School
of Health Sciences, University of Minho, Braga, and from the
Centro Hospitalar do Alto Ave, EPE, Guimara˜es. The same
demographic and clinical data as well as exclusion criteria
were applied. The study design and procedures were ap-
proved by the local research ethics committee. All enrolled
women gave written informed consent.
Assessment of iodine status
Urine samples were collected from pregnant women in
each trimester of pregnancy (12 1, 24 1, and 32 1 weeks),
during labor, and 3 days, 3 months, and 1 year after delivery.
One random urine sample was collected from the nonpreg-
nant women. Urine samples from the infants were collected
3 days and 3 months after birth. The urinary samples were
collected in the morning and, whenever possible, in the fasting
state, in a screw-capped plastic bottle, with no added preser-
vative. Aliquots were stored frozen at 808C until use. Breast
milk was also obtained at 3 days and 3 months after delivery,
whenever available. Milk samples were similarly collected
and stored. UI was measured by the ammonium persulfate
method (1), and milk iodine concentrations were measured by
a modification of the chloric acid digestion method (1). Results
were expressed as mg=L.Determinationswere repeated in sam-
ples with values below 50mg=L or above 300mg=L.
Pregnant women and their progeny had ultrasound ex-
amination of the thyroid to determine the thyroid volume and
to evaluate the echo texture of the gland. The examinationwas
performed with a real-time Philips HD II instrument (Eind-
hoven, The Netherlands) with a 7.5MHz, 50-mm Gemini
linear transducer L12-5. Thyroid volume was calculated as
the sum of maximal lengthwidthdepthp=6 of each lobe
(isthmus not included) (1). Thyroid volume of the women
was assessed in the third trimester of pregnancy and repeated
3–6months after delivery. The glandwas considered enlarged
when the volume was >18mL, which corresponds to the
meanþ 3SDs of the volume in iodine-sufficient populations
(9). It was classified as goiter when the volume was more
than 22mL (9). When the echo texture of the gland was not
homogeneous, showing small lesions or distinct diffuse ab-
normalities, it was classified as heterogeneous. Thyroid vol-
ume was similarly calculated for infants at 3 months of age.
Information on neonatal TSH concentration was obtained
from the National Congenital Hypothyroidism Screening
Program that was performed at the Instituto de Gene´tica
Me´dica Dr. Jacinto Magalha˜es, Porto. TSH measurements
were done on blood samples collected between 3 and 6 days
after birth by the Delfia (immunofluorescence) method in a
Perkin Elmer Trade Mark (Zaventem, Belgium). The cutoff
for congenital hypothyroidism was established at 20mIU=L.
Statistical analyses
Data are presented as mean SD or median with inter-
quartile range. For variables exhibiting a skewed distribution,
the median was used as the measure of central tendency to-
gether with the interquartile range. Logarithmic transforma-
tions were also done for these variables. Comparisons were
made using the t-test or the nonparametric Mann–Whitney
test. Correlations between neonatal and maternal variables
were performed using the Pearson correlation or Spearman’s
rank correlation tests. Statistical analyses were performed
using the SPSS 15 software package (SPSS, Chicago, IL). Va-
lues were considered significant when p< 0.05. All tests were
two sided.
Results
Demographic data
The demographic data of women are presented in Table 1.
From the questionnaire, three of the nonpregnant women
reported to suffer from epilepsy and two from asthma. With
respect to the pregnant women, all were breast-feeding 3 days
after delivery and 81 continued for at least 3 months, with
no information available in 16 cases. Six of the pregnancies
were multiple, and three women became pregnant a second
time during the study period. All pregnant women were re-
cruited from a high-risk obstetrical consultation, and had been
sent because of previous pathologies: abortion (n¼ 32), hy-
pertension (n¼ 79), and psychological=psychiatric disorders
(n¼ 13). In the pregnancy under study, 23 had gestational
diabetes and 16 had gestational hypertension. No women
reported the use of iodine supplements or of iodized salt or
to be vegetarians. Pregnant and nonpregnant women were
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similar in age and fish consumption, but were significantly
different in the number of previous pregnancies and socio-
economic status (z¼6.6, p< 0.05; t¼4.6; p< 0.05).
Table 2 presents information on the newborn babies. Three
of the newborns were with very low birth weight (<1500 g),
and 14 low birth weight (<2500 g); 3 were macrosomic
(>4000 g), and 29 were admitted to the Neonatology Unit (for
prematurity, low birth weight, sepsis, or hyperbilirubinemia),
where 1 died.
Urinary and milk iodine
Table 3 presents the median UI for women and babies and
milk iodine, as well as the percentage of individuals within
the iodine classes as defined by theWHO (1–3,11,12). Figure 1
depicts the cumulative percentage of women taking into
consideration the cutoff of iodine sufficiency for the pregnant
population (>150mg=L) and for the nonpregnant popula-
tion (>100 mg=L) (1–3,11,12). Nonpregnant women had a
median UI of 75mg=L, which is below the median of 100 mg=L
expected for the general population in an iodine-sufficient
population (1–3,11–13). UI did not correlate with women’s
age, parity, socioeconomic status, or fish consumption. How-
ever, when comparing women with U <50 mg=L with those
with UI$ 50mg=L, the lower UI was associated with lower
socioeconomic status (t¼ 2.2, p< 0.05) and more pregnancies
(t¼ 2.7, p< 0.05).
Pregnant women also displayed UI below those re-
commended for pregnancy. After delivery and lactation, UI
was still lower than the recommended values. Notably, wo-
men had lower UI 1 year after delivery than throughout
pregnancy. A comparison made at the first trimester of
pregnancy between womenwith UI below (n¼ 52) and above
(n¼ 84) 50mg=L indicated that the lowerUIwere fromwomen
Table 1. Demographic Characteristics of the Women
Pregnant
women
Nonpregnant
women
n 140 78
Age (years) (mean SD) 30.1 6.7 29.4 6.5
Previous pregnancies
(mean SD)
2.3 1.5 1.05 1.1
Medium-high socioeconomic
status (%)
53.6 79.5
Fish consumption
No. of times=week (mean SD) 1.5 0.7 1.4 0.7
Less than three times=week (%) 51.4 53.8
Table 2. Demographic Characteristics of the Progeny
n 142
Sex: girls=boys 66=76
Gestational age (weeks) (mean SD) 37.9 2.0
Type of delivery
Cesarean 43.7%
Vaginal 56.3%
Birth weight (g) (mean SD) 3111 514
Length at birth (cm) (mean SD) 48.5 2.4
Head circumference (cm) (mean SD) 34.2 1.5
Apgar score at 1min (mean SD) 8.8 0.9
Apgar score at 5min (mean SD) 9.8 0.8
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with a lower socioeconomic status (t¼ 3.0, p< 0.05). No sta-
tistically significant differences were found when age, parity,
or fish consumption were considered.
There was no correlation between UI during or after preg-
nancy and women’s age or parity. There was a weak negative
correlation between UI in the third trimester and socioeco-
nomic status (R¼0.200, p< 0.05). In pregnant women there
was also a weak correlation between fish consumption and
age (R¼ 0.245, p< 0.01), and a negative correlation between
fish consumption and socioeconomic status (R¼0.266,
p< 0.01). When UI of women after delivery was considered
in relation to breast-feeding no differences were found. Three
months after delivery, women breast-feeding (n¼ 55) had
median UI of 46 mg=L, while the formula-feeding ones (n¼ 36)
had median UI of 49mg=L.
Breastmilk iodinewas also below the recommended values
of 150–180 mg=L (4,14), with amedian of 95 mg=L at 3 days and
of 70mg=L at 3 months after delivery. Iodine in breast milk
correlated with UI at 3 days (R¼ 0.440, p< 0.01) and 3months
(R¼ 0.456, p< 0.01) after delivery. There were no correlations
between iodine in breast milk and women’s parity, fish con-
sumption, socioeconomic class, thyroid volume 3 months
after pregnancy (see thyroid volume section), gestational age,
or birth weight of the newborn.
Median UI of the progeny measured both at 3 days and
at 3 months were below that accepted for iodine sufficiency
(1–3). When comparing the UI of 3-day-old and 3-month-old
babies bypaired samples tests (n¼ 20), therewas a trend forUI
to increase with age (median of 70 vs. 103mg=L, respectively),
but this did not reach statistical significance. At 3 months the
median UI of the babies (n¼ 64) was 96mg=L. Notably, when
grouped according to their mode of feeding (Fig. 2), those on
formulas (n¼ 24) had a median UI of 137mg=L, on breast
milk (n¼ 34) amedianUI of 80mg=L, and on both formula and
breast milk (n¼ 6) a median UI of 93mg=L, with these differ-
ences being statistically significant (z¼2.5, p< 0.05). We did
not find differences in neonatal TSH or thyroid volume in
babies related to their mode of feeding.
There was no relationship between the babies’ UI either
at 3 days or at 3 months of gestational age and birth weight,
type of delivery, neonatal TSH, or neonatal thyroid volume
(see below), or with the mother’s age, socioeconomic status,
parity, or fish consumption.
Thyroid volume
The mean thyroid volume in the third trimester was
14.8 4.7mL. Twenty-three percent of the women had an
enlarged gland (>18mL), 13.8% had goiter (>22mL), and
12.6% had heterogeneity of their ultrasound pattern. The
corresponding mean value for thyroid volume 3 months after
delivery was 11.9 5.3mL. Thyroid enlargement was noted
in 14.5%, and 5.8% had goiter. Heterogeneity was noted in
23.3%. The mean thyroid volume in babies at 3 months of age
was 0.6 0.4mL.
There was no correlation between thyroid volume of the
mothers either during or after pregnancy and age, parity,
socioeconomic status, or UI. There was a weak negative
correlation between thyroid volume in the third trimester
and fish consumption (R¼0.255, p< 0.05), but this was not
noted 3 months after delivery. Thyroid volume in the third
FIG. 1. Cumulative per-
centage of women, taken into
consideration the cutoff of
urinary iodine (UI) concentra-
tion sufficiency for pregnant
(>150 mg=L) and nonpreg-
nant (>100 mg=L) women.
FIG. 2. Percentage of babies with UI concentration, as de-
fined by the World Health Organization, according to the
type of feeding.
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trimester correlated positively with thyroid volume 3 months
after delivery (R¼ 0.478, p< 0.01). Thyroid volume in babies
did not correlate with their gestational age, birth weight,
neonatal TSH, or UI at 3 days or 3 months. The percentage
of babies with thyroid volume above the 75th percentile, ad-
justed for age, sex, and body surface area, was 16.2.
Neonatal TSH
In 117 newborns mean neonatal TSH was 1.6 1.2mUI=L.
Only one baby had a TSH >5mUI=L, and the percentile 75th
was 2.1mUI=L. The neonatal TSH did not correlate with the
babies’ gestational age, birth weight, thyroid volume, or UI
collected at 3 days or 3 months. There were no differences
in the neonatal TSH, UI, or thyroid volume in babies born of
women (n¼ 34) with UI of <50mg=L in the third trimester
of pregnancy compared to those born of women (n¼ 65) with
UI of $50 mg=L during a similar period of pregnancy.
Correlations mothers–progeny
TheUI, neonatal TSH, and thyroid volume of the babies did
not correlate with their mother’s age, socioeconomic status,
parity, or fish consumption, or with their gestational age or
birth weight. Correlations were sought for between the
mother’s UI when collected at various times (third trimester
and 3 days and 3 months after delivery) and the thyroid
volume during and after pregnancy, the iodine content in
breast milk at 3 days and 3 months after delivery, and off-
spring’s neonatal TSH, thyroid volume, and UI. Significant
but weak correlations were found for mother’s UI 3 months
after delivery and the infant’s UI at 3 months (R¼ 0.42,
p< 0.05), breast milk content 3 days after delivery and infant’s
UI at 3 days (R¼ 0.51, p< 0.05), and breast milk content
3 months after delivery and the infant’s UI at 3 months
(R¼ 0.44, p< 0.05).
Discussion
The data presented in this study clearly show that Por-
tuguese women of the Minho region and their progeny have
a UI concentration strongly indicative of ID, as defined by
criteria established by the WHO (1–4). In all groups (61%
of nonpregnant, 76–91% of women throughout pregnancy,
66–92% after pregnancy, 62% of the newborns, and 52% of the
infants) the median UI was under the newly accepted values
that are considered desirable. These are above 100mg=L for
the general population, for lactating women, and for children
under 2 years of age, and 150–249 mg=L throughout preg-
nancy. Moreover, the percentage of samples with U<50 mg=L
was higher than 20, the accepted percentage for an iodine-
sufficient population. It was 36 for nonpregnant women,
28–38 for pregnant women, 49–60 for women after delivery,
32 for newborns, and 21 for infants. These results are similar
to others found in iodine-deficient areas (11–18).
The reductions in UI concentrations noted in this study
are undoubtedly due to insufficient iodine intake, probably
due to the lack of a policy of universal salt iodination in Por-
tugal and from the absence of general medical advice on
supplementing pregnant and lactating women with iodine.
In addition, despite the proximity to the sea, the Portuguese
population of the Minho region, particularly in the lower
socioeconomic classes, has a low fish-consumption rate as
revealed by the food questionnaire (19). Even when fish is
included in the diet, its content of iodine may depend on
whether it originates from the sea or from farms. Of note, un-
expected ID has been observed in other coastal areas (1–3,16).
While urinary iodine excretion is the most appropriate in-
dicator for assessing recent iodine intake in epidemiological
studies, other indices such as goiter are clinical hallmarks
of ID (1–3,20–26). In our study almost 14% of all pregnant
women had gestational goiter, and heterogeneous echotex-
ture patterns after pregnancy were often observed. This is
in agreement with reports from other iodine-insufficient
populations (23–25). In addition, the thyroid volume during
pregnancy correlated with that observed after pregnancy,
indicating that thyroid enlargement only partially reverted
after delivery. This observation provides additional evidence
for ID. Unlike other studies, we did not find any relation
between thyroid volume and age, previous pregnancies, so-
cioeconomic status, urinary or breast milk iodine, or the
progeny’s thyroid volume (21–26), but only with the fish-
consumption rate (25).
Iodine insufficiency was also reflected in the data for breast
milk iodine concentrations obtained in this study. This is
particularly relevant to the complications of ID because breast
milk is usually the only source of iodine for newborns. Breast
milk iodine is considered sufficient when values are in the
range of 150–180 mg=L (4,11,14,17,18,27–35). The median io-
dine content in breast milk was lower than this in our study.
Similarly to other published data, we also observed a positive
correlation between the iodine content of breast milk and that
of the nursing infant’s urine (27–35). Considering that all of
the women were breast-feeding on day 3 and 58%were doing
so 3 months later, a high percentage of the infant population
in the study area were probably not getting adequate iodine
for thyroid hormone synthesis and storage (31–34). In fact,
assuming a daily intake of 150mL=kg (about 500mL milk for
the newborns and 750mL for 3-month-old infants), these ba-
bies were getting about half of the recommended daily dose
of iodine (1–3,31,35). Notably, infants taking formula milk at
3 months had a median UI significantly higher than breastfed
infants (137 vs. 80 mg=L). This could be due either to higher
iodine content or to lower bioavailability of iodine in formula
milk compared to breast milk or a combination of the two
(11,28,34).
The best criteria for assessing the degree of ID in new-
borns have not been established because of lack of sufficient
data for UI in this group. Other potential indices of ID, such
as neonatal TSH, are not completely reliable due to many
factors, including the timing of sample collection (1–4,32,
35,36). Although the present study showed that the new-
borns met the WHO criteria for desirable serum TSH con-
centrations (considered iodine sufficient if less than 3% of
the newborns have TSH >5mU=L), it is now well recognized
that the regulation of TSH secretion in the newborn does
not follow the same feedback mechanisms observed when
the thyroid–pituitary axis is fully developed (6). Therefore,
the cutoffs for defining severity of ID on the basis of newborn
TSH concentrations originally proposed by the WHO have
been questioned and are not considered in most of the recent
recommendations (3).
Another proposed indicator of ID is the thyroid volume.
In the present study, when adjusted for sex, age, and body
surface, we found a relatively high percentage of children
with thyroid volumes above the 75th percentile (37,38). These
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results were not expected because the development of neo-
natal goiter from intrauterine iodine restriction is believed
to be prevented by a prenatal iodine intake that results in
neonatal UI higher than 50mg=L (39) as was observed in the
present case study.
In summary, our data suggest that pregnant and lactating
women of the Minho region are iodine deficient. This may
compromise the proper development of their offspring, and
impact adversely on the psychomotor and intellectual perfor-
mance of future generations. The WHO technical commission
published, last December, a consensus about the strategy to
eliminate IDD (18). According to this and to other recom-
mendations (40), considering the lack of reliable information
regarding iodine nutrition from other areas, and based on the
results presented here, we strongly recommend that all Por-
tuguese pregnant and lactating women, as well as women of
fertile age, receive iodine supplements.
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